Carregant...
Drug Resistance in Leishmaniasis
The treatment options of leishmaniasis are limited and far from satisfactory. For more than 60 years, treatment of leishmaniasis has centered around pentavalent antimonials (Sb(v)). Widespread misuse has led to the emergence of Sb(v) resistance in the hyperendemic areas of North Bihar. Other antilei...
Guardat en:
Autors principals: | , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Medknow Publications
2010
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2889657/ https://ncbi.nlm.nih.gov/pubmed/20606973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-777X.62887 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|